Latest filings (excl ownership)
10-Q
2024 Q2
Quarterly report
8 Aug 24
8-K
Natera Reports Second Quarter 2024 Financial Results
8 Aug 24
8-K
Other Events
19 Jul 24
S-8
Registration of securities for employees
15 Jul 24
8-K
Departure of Directors or Certain Officers
18 Jun 24
DEFA14A
Additional proxy soliciting materials
5 Jun 24
10-Q
2024 Q1
Quarterly report
9 May 24
8-K
Natera Reports First Quarter 2024 Financial Results
9 May 24
ARS
2023 FY
Annual report to shareholders
24 Apr 24
DEFA14A
Additional proxy soliciting materials
24 Apr 24
DEF 14A
Definitive proxy
24 Apr 24
S-8
Registration of securities for employees
29 Feb 24
10-K
2023 FY
Annual report
28 Feb 24
8-K
Natera Reports Fourth Quarter and Full Year 2023 Financial Results
28 Feb 24
8-K
Natera Acquires Reproductive Health Assets from Invitae
22 Jan 24
8-K
Natera Announces Preliminary Fourth Quarter and Full Year 2023 Revenues
9 Jan 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
8-K
Natera Reports Third Quarter 2023 Financial Results
8 Nov 23
8-K
Natera Launches Proposed Follow-On Offering
7 Sep 23
424B5
Prospectus supplement for primary offering
7 Sep 23
S-3ASR
Automatic shelf registration
6 Sep 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
8-K
Natera Reports Second Quarter 2023 Financial Results
3 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
15 Jun 23
10-Q
2023 Q1
Quarterly report
9 May 23
8-K
Natera Reports First Quarter 2023 Financial Results
9 May 23
8-K
Departure of Directors or Certain Officers
21 Apr 23
ARS
2022 FY
Annual report to shareholders
20 Apr 23
DEFA14A
Additional proxy soliciting materials
20 Apr 23
DEF 14A
Definitive proxy
20 Apr 23
8-K
Regulation FD Disclosure
10 Mar 23
S-8
Registration of securities for employees
1 Mar 23
10-K
2022 FY
Annual report
1 Mar 23
8-K
Natera Reports Fourth Quarter and Full Year 2022 Financial Results
28 Feb 23
8-K
Departure of Directors or Certain Officers
23 Feb 23
POSASR
Automatic shelf registration (post-effective amendment)
6 Dec 22
8-K
Natera Launches Proposed Follow-On Offering
16 Nov 22
424B5
Prospectus supplement for primary offering
16 Nov 22
S-3ASR
Automatic shelf registration
15 Nov 22
10-Q
2022 Q3
Quarterly report
8 Nov 22
Latest ownership filings
4
Steven Leonard Chapman
16 Aug 24
4
Jonathan Sheena
16 Aug 24
144
Notice of proposed sale of securities
15 Aug 24
4
Jonathan Sheena
14 Aug 24
4
John Fesko
14 Aug 24
144
Notice of proposed sale of securities
12 Aug 24
4
Matthew Rabinowitz
9 Aug 24
4
DANIEL RABINOWITZ
31 Jul 24
4
Solomon Moshkevich
31 Jul 24
4
John Fesko
31 Jul 24
4
Steven Leonard Chapman
31 Jul 24
4
Michael Burkes Brophy
31 Jul 24
144
Notice of proposed sale of securities
31 Jul 24
4
HERM ROSENMAN
30 Jul 24
4
JAMES HEALY
30 Jul 24
4
ROELOF BOTHA
30 Jul 24
4
Roy D. Baynes
30 Jul 24
4
Michael Burkes Brophy
26 Jul 24
144
Notice of proposed sale of securities
26 Jul 24
144
Notice of proposed sale of securities
24 Jul 24
4
Michael Burkes Brophy
23 Jul 24
4
Solomon Moshkevich
23 Jul 24
4
John Fesko
23 Jul 24
4
Steven Leonard Chapman
23 Jul 24
4
Jonathan Sheena
23 Jul 24
4
DANIEL RABINOWITZ
23 Jul 24
4
Steven Leonard Chapman
17 Jul 24
144
Notice of proposed sale of securities
15 Jul 24
4
Jonathan Sheena
2 Jul 24
4
DANIEL RABINOWITZ
2 Jul 24
4
Steven Leonard Chapman
2 Jul 24
4
Michael Burkes Brophy
2 Jul 24
4
Brinkley Ruth Williams
2 Jul 24
4
HERM ROSENMAN
2 Jul 24
4
Gail Boxer Marcus
2 Jul 24
4
JAMES HEALY
2 Jul 24
4
Rowan E Chapman
2 Jul 24
4
ROELOF BOTHA
2 Jul 24
4
Roy D. Baynes
2 Jul 24
144
Notice of proposed sale of securities
1 Jul 24